I posted recently on the EA forum about the Organisation for the Prevention of Intense Suffering (OPIS) initiative on access to psilocybin for cluster headaches. Our policy paper has now been published. Policy recommendations include allowing doctors to prescribe currently restricted substances such as psilocybin, LSD, DMT and 5-MeO-DALT to patients with cluster headaches and ensuring that these substances can be readily produced or imported for such medical use. It is also recommended to modify regulations to ensure that patients who purchase or possess small amounts of psychoactive substances for personal therapeutic use cannot be charged with a crime or offence.

Some of the arguments we make:

  1. Randomised controlled trials are not the only form of strong evidence in determining whether a substance is effective. Although we don't go into detail in making probability estimates, we state that "it is vanishingly improbable that the dramatic effect observed independently by so many patients was due to chance or artefact."
  2. Aside from their efficacy, psilocybin and related substances are probably safer to use than many standard cluster headache treatments.
  3. It is an imperative to alleviate extreme suffering according to any mainstream ethical framework.
  4. When standard medical options are unsatisfactory, it is entirely reasonable for a patient in excruciating pain to seek alternatives. Criminalising reasonable behaviour is unreasonable.
  5. A shift in drug policies towards general decriminalisation/legalisation would lead to harm reduction.

Our paper was co-signed by several neurologists, ethicists and other experts, including Peter Singer, Julian Savulescu, Brian Earp and David Nutt, and has been promoted by the International Drug Policy Consortium (IDPC).

In order to convey the seriousness of cluster headaches and the need for legalising access to effective treatments, we also produced a 2-minute animated video.


 

Comments5


Sorted by Click to highlight new comments since:

Well done on this, important work and a strong set of signatories.

Thank you for this post. I just recently heard the first time of cluster headaches and OPIS work in general. It really looks promising to me. Did OPIS also look into the research for capsaicin? For example https://youtu.be/bSeYYXlH1MQ

Thanks for this link, Simon. Some cluster headache patients do report trying things like "Sinus Plumber" (which contains capsaicin), but I don't see it being widely recommended as a treatment. I'm not sure how many patient support groups are even aware of the study cited in this video, and among those patients who try capsaicin, it seems the expectation is that it might work rapidly as an abortive, rather than as a preventative following several applications. I will follow up on this with some patient groups I'm in contact with.

Congratulations! Brilliant to see a combined advocacy approach too - if you don't mind sharing, how did you go about producing the accompanying video? I'm keen to introduce more media into my own advocacy work so I'm keen to learn.

Thanks! I wrote a description of the storyboard, used my network to find an illustrator who does animation, worked closely with her to get the images right, found the right music and then edited the video myself, mainly using Final Cut.

Curated and popular this week
 ·  · 1m read
 · 
I recently read a blog post that concluded with: > When I'm on my deathbed, I won't look back at my life and wish I had worked harder. I'll look back and wish I spent more time with the people I loved. Setting aside that some people don't have the economic breathing room to make this kind of tradeoff, what jumps out at me is the implication that you're not working on something important that you'll endorse in retrospect. I don't think the author is envisioning directly valuable work (reducing risk from international conflict, pandemics, or AI-supported totalitarianism; improving humanity's treatment of animals; fighting global poverty) or the undervalued less direct approach of earning money and donating it to enable others to work on pressing problems. Definitely spend time with your friends, family, and those you love. Don't work to the exclusion of everything else that matters in your life. But if your tens of thousands of hours at work aren't something you expect to look back on with pride, consider whether there's something else you could be doing professionally that you could feel good about.
 ·  · 14m read
 · 
Introduction In this post, I present what I believe to be an important yet underexplored argument that fundamentally challenges the promise of cultivated meat. In essence, there are compelling reasons to conclude that cultivated meat will not replace conventional meat, but will instead primarily compete with other alternative proteins that offer superior environmental and ethical benefits. Moreover, research into and promotion of cultivated meat may potentially result in a net negative impact. Beyond critique, I try to offer constructive recommendations for the EA movement. While I've kept this post concise, I'm more than willing to elaborate on any specific point upon request. Finally, I contacted a few GFI team members to ensure I wasn't making any major errors in this post, and I've tried to incorporate some of their nuances in response to their feedback. From industry to academia: my cultivated meat journey I'm currently in my fourth year (and hopefully final one!) of my PhD. My thesis examines the environmental and economic challenges associated with alternative proteins. I have three working papers on cultivated meat at various stages of development, though none have been published yet. Prior to beginning my doctoral studies, I spent two years at Gourmey, a cultivated meat startup. I frequently appear in French media discussing cultivated meat, often "defending" it in a media environment that tends to be hostile and where misinformation is widespread. For a considerable time, I was highly optimistic about cultivated meat, which was a significant factor in my decision to pursue doctoral research on this subject. However, in the last two years, my perspective regarding cultivated meat has evolved and become considerably more ambivalent. Motivations and epistemic status Although the hype has somewhat subsided and organizations like Open Philanthropy have expressed skepticism about cultivated meat, many people in the movement continue to place considerable hop
 ·  · 7m read
 · 
Introduction I have been writing posts critical of mainstream EA narratives about AI capabilities and timelines for many years now. Compared to the situation when I wrote my posts in 2018 or 2020, LLMs now dominate the discussion, and timelines have also shrunk enormously. The ‘mainstream view’ within EA now appears to be that human-level AI will be arriving by 2030, even as early as 2027. This view has been articulated by 80,000 Hours, on the forum (though see this excellent piece excellent piece arguing against short timelines), and in the highly engaging science fiction scenario of AI 2027. While my article piece is directed generally against all such short-horizon views, I will focus on responding to relevant portions of the article ‘Preparing for the Intelligence Explosion’ by Will MacAskill and Fin Moorhouse.  Rates of Growth The authors summarise their argument as follows: > Currently, total global research effort grows slowly, increasing at less than 5% per year. But total AI cognitive labour is growing more than 500x faster than total human cognitive labour, and this seems likely to remain true up to and beyond the point where the cognitive capabilities of AI surpasses all humans. So, once total AI cognitive labour starts to rival total human cognitive labour, the growth rate of overall cognitive labour will increase massively. That will drive faster technological progress. MacAskill and Moorhouse argue that increases in training compute, inference compute and algorithmic efficiency have been increasing at a rate of 25 times per year, compared to the number of human researchers which increases 0.04 times per year, hence the 500x faster rate of growth. This is an inapt comparison, because in the calculation the capabilities of ‘AI researchers’ are based on their access to compute and other performance improvements, while no such adjustment is made for human researchers, who also have access to more compute and other productivity enhancements each year.